Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


U-Create 2-day bootcamp

Publication date: Jan 29, 2013 10:52 AM

Start: Feb 09, 2013 09:30 AM

Location: UCL, Cruciform B404 LT2, Gower Street, WC1E 6BT, London

U-Create

U-Create is a fantastic opportunity that will challenge you to combine creativity with enterprise.

Participants will be placed in teams and given a design brief. Over two days, they will brainstorm, research and pitch their concepts. Successful teams will get the opportunity to take their designs to the next level – manufacture and launch to market. 

Find out more at: www.ucl.ac.uk/u-create